Mycophenolate mofetil‐induced peripheral neuropathy in the treatment of membranous glomerulonephropathy: A case report. Issue 12 (13th December 2021)

• Record Type: Journal Article
• Authors: Moghimi, Minoo; Nekoukar, Zahra; Gholami, Farhad
• Is Part Of: Clinical case reports. Volume 9:Issue 12(2021)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2021-12-13
• Subjects: membranous glomerulonephropathy -- mycophenolate mofetil -- peripheral neuropathy; Medicine -- Periodicals; 616.09
• DOI: 10.1002/ccr3.5161
• Languages: English
• ISSNs: 2050-0904

Abstract

Abstract: Mycophenolate mofetil (MMF) as an immunosuppressive agent is widely used in the management of Membranous Glomerulonephropathy (MGN). In this report, we described a 66‐year‐old male MGN case treated with MMF and revealed acquired sensory‐motor axonal polyneuropathy, which is rare and has not been reported before. Abstract : Although mycophenolate mofetil is effective in the management of some immune‐mediated neuromuscular disorders, it could inversely cause peripheral neuropathy as a rare side effect, which is hopefully reversible with drug discontinuation.